-
1.GLYCOGEN SYNTHASE KINASE 3BETA INHIBITOR, COMPOSITION AND PROCESS FOR THE PREPARATION THEREOF 审中-公开
标题翻译: 糖原合酶激酶3β的抑制剂,组合物和方法及其公开(公告)号:EP1590333A4
公开(公告)日:2008-04-30
申请号:EP04703520
申请日:2004-01-20
申请人: CRYSTALGENOMICS INC , YUYU INC
发明人: CHO JOONG MYUNG , RO SEONGGU , LEE TAE GYU , LEE KYUNG JOO , SHIN DONGKYU , HYUN YOUNG-LAN , LEE SEUNG CHUL , KIM JIN HWAN , JEON YOUNG HO
IPC分类号: C07D235/18 , A61K31/4184 , A61P3/00 , C07D235/24
CPC分类号: C07D235/18 , C07D401/12 , C07D403/12 , C07D409/12
-
2.PHARMACEUTICAL COMPOSITION INCLUDING 5-{4-(AMINOSULFONYL)PHENYL}-2,2-DIMETHYL-4-(3-FLUOROPHENYL)-3(2H)-FURANONE AND CAPSULE FORMULATION INCLUDING THE PHARMACEUTICAL COMPOSITION 审中-公开
标题翻译: (4-氟苯基)-2,2-二甲基-4-(3-氟苯基)-3(2H) - 呋喃酮公开(公告)号:EP3099294A4
公开(公告)日:2017-09-06
申请号:EP15742755
申请日:2015-01-29
申请人: CRYSTALGENOMICS INC
发明人: KIM BYUNG-HA , AHN SIK IL , PARK JAE-YEON , KIM TAE RYONG , CHO JOONG MYUNG , RO SEONGGU
CPC分类号: A61K31/34 , A61K9/485 , A61K9/4858 , A61K9/4866 , A61K31/397 , A61K31/42
摘要: The present invention relates to a pharmaceutical composition including (i) the compound of Formula 1 described in the specification or a pharmaceutically acceptable salt thereof, (ii) a pharmaceutically acceptable diluent, and (iii) a pharmaceutically acceptable lubricant. The compound of Formula 1 or pharmaceutically acceptable salt thereof has a 50% volume particle diameter (d(0.5)) of 3 μm to 9 μm. The pharmaceutical composition of the present invention has the advantages of good stability, high dissolution rate, improved content uniformity, and excellent pharmacokinetic properties. Due to these advantages, the pharmaceutical composition of the present invention is effective in treating inflammation or pain.
摘要翻译: 本发明涉及药物组合物,其包含(i)说明书中描述的式1的化合物或其药学上可接受的盐,(ii)药学上可接受的稀释剂,和(iii)药学上可接受的润滑剂。 式1的化合物或其药学上可接受的盐具有3μm至9μm的50%体积粒径(d(0.5))。 本发明的药物组合物具有稳定性好,溶出速率快,含量均匀性好,药代动力学性能好等优点。 由于这些优点,本发明的药物组合物在治疗炎症或疼痛方面是有效的。
-
公开(公告)号:EP2188295A4
公开(公告)日:2011-11-16
申请号:EP08831492
申请日:2008-08-08
申请人: CRYSTALGENOMICS INC
发明人: KIM SUN NAM , HONG YONG RAE , SHIN DONGKYU , RO SEONGGU , CHO JOONG MYUNG , LEE MI JUNG , CHANG HO JIN
IPC分类号: C07D495/04 , C07D471/04 , C07D491/048
CPC分类号: C07D495/04 , C07D471/04 , C07D491/048
-
4.ALKYLCARBAMOYL NAPHTHALENYLOXY- OCTENOYLHYDROXYAMIDE DERIVATIVES HAVING INHIBITORY ACTIVITY AGAINST HISTONE DEACETYLASE AND PREPARATION THEREOF 审中-公开
标题翻译: 具有抑制作用的生产和组蛋白去乙酰ALKYLCARBAMOYLNAPHTHALINYLOXYOCTENOYLHYDROXYAMIDDERIVATE公开(公告)号:EP1945606A4
公开(公告)日:2010-05-05
申请号:EP06812321
申请日:2006-10-31
发明人: LEE CHEOL HAE , JUNG HEE JUNG , KIM JAE HAK , JEONG WON JANG , CHO JOONG MYUNG , RO SEONGGU , HYUN YOUNG LAN , SHIN DONGKYU , LEE CHEOL SOON
IPC分类号: C07C237/32 , A61K31/165 , A61K31/175 , A61K31/40 , A61K31/445 , A61K31/495 , A61P35/00 , C07C259/06 , C07D207/14 , C07D211/58 , C07D295/13
CPC分类号: C07C259/06 , C07C2601/14 , C07C2601/16 , C07D207/12 , C07D207/14 , C07D211/58 , C07D213/75 , C07D233/54 , C07D233/61 , C07D295/185 , C07D307/66 , C07D333/20
-
5.2,3-DIHYDRO-ISOINDOLE-1-ON DERIVATIVE AS BTK KINASE SUPPRESSANT, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME 审中-公开
标题翻译: 2,3-二氢 - 异吲哚-1-酮衍生物作为BTK激酶抑制剂和药物组合物,其公开(公告)号:EP2940014A4
公开(公告)日:2016-06-22
申请号:EP13867650
申请日:2013-12-26
申请人: CRYSTALGENOMICS INC
发明人: HONG YONG RAE , NA JEONG EUN , MIN IM SOOK , CHA HYUN JU , KWON SOOL KI , RO SEONGGU , CHO JOONG MYUNG
IPC分类号: C07D403/04 , A61K31/4178 , A61P25/00 , A61P35/00
CPC分类号: C07D403/10 , A61K31/4178 , A61K45/06 , C07D403/04
摘要: The present invention provides a compound selected from the group consisting of a compound of formula (I), pharmaceutically acceptable salts, esters, prodrugs, hydrates, solvates and isomers thereof; a use of the compound for the treatment, relief or prevention of diseases caused by absormal or uncontrolled activation of protein kinase, and a use of the compound for the manufacture of a medicament for the treatment, relief or prevention of the diseases; a pharmaceutical composition comprising the compound as an active ingredient; and a method for the treatment, relief or prevention of the diseases using the compound. The inventive compound is useful for the treatment, relief or prevention of diseases caused by abnormal or uncontrolled activation of protein kinase.
-
6.NAPHTHALENYLOXYPROPENYL DERIVATIVES HAVING INHIBITORY ACTIVITY AGAINST HISTONE DEACETYLASE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME 审中-公开
标题翻译: 具有锁定效应对蛋白去乙酰化酶,和药物组合物包含此NAPHTHALINYLOXYPROPENYLDERIVATE公开(公告)号:EP2089354A4
公开(公告)日:2014-08-13
申请号:EP07833799
申请日:2007-11-01
发明人: LEE CHEOL HAE , JUNG HEE JUNG , KIM JAE HAK , JEONG WON JANG , CHO JOONG MYUNG , RO SEONG GU , HYUN YOUNG LAN , LEE CHEOL SOON
IPC分类号: C07C233/22 , C07C217/16 , C07C217/18 , C07C233/16
CPC分类号: C07C259/10 , C07C259/06 , C07C2601/14 , C07C2601/16 , C07D207/27 , C07D207/335 , C07D211/10 , C07D211/58 , C07D233/64 , C07D295/13 , C07D307/14 , C07D307/52 , C07D333/20
-
公开(公告)号:EP2226315A4
公开(公告)日:2012-01-25
申请号:EP08869161
申请日:2008-12-26
发明人: SAWA MASAAKI , YOKOTA KOICHI , MORIYAMA HIDEKI , SHIN MYOUNGYOUP , RO SEONGGU , CHO JOONG MYUNG
IPC分类号: C07D239/84 , A61K31/517 , A61K31/5377 , A61P3/00 , A61P5/00 , A61P9/00 , A61P11/06 , A61P19/08 , A61P25/00 , A61P25/28 , A61P29/00 , A61P35/00 , A61P37/06 , A61P37/08 , A61P43/00 , C07D401/14 , C07D403/12 , C07D405/12 , C07D413/12 , C07D417/12
CPC分类号: C07D239/84 , C07D401/14 , C07D403/12 , C07D405/12 , C07D413/12 , C07D417/12
-
公开(公告)号:EP1948601A4
公开(公告)日:2011-04-06
申请号:EP06799211
申请日:2006-10-13
申请人: CRYSTALGENOMICS INC
发明人: KIM CHEOL MIN , HYUN YOUNG LAN , SHIN DONG KYU , RO SEONGGU , CHO JOONG MYUNG
IPC分类号: C07D209/18 , C07D471/04 , C07D487/04 , C07D495/04
CPC分类号: C07D213/64 , C07D213/69 , C07D213/70 , C07D213/74 , C07D237/16 , C07D239/47 , C07D239/52 , C07D401/06 , C07D401/12 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D413/06 , C07D413/12 , C07D413/14 , C07D417/06 , C07D417/14
-
-
-
-
-
-
-